
Why White HIV Leadership Needs to Give Reins to Black Leaders
Racial and generational equity demand that leaders with “founder’s syndrome” transfer knowledge, relationships, and connections to new leaders in the movement to end HIV.

This Week in HIV Research: The Importance of Challenging Our Assumptions
Feb. 25, 2021: High HCV SVR among people using substances; geographic HIV care disparities among Black Americans; self-administered imiquimod vs. ASIL excision; PrEP uptake in syringe service programs.

Elevated Dementia Risk Persists Among Older People Living With HIV
Even among people on modern HIV treatment, just over a quarter of PLWH are diagnosed with dementia by age 80, compared to just under 14% of HIV-negative people, according to a new U.S. study.

Here’s How a Leading HIV Advocate Responds to COVID-19 Vaccine Mistrust
In the health care field, we are finally beginning to turn the mirror around and ask, “What are we doing wrong if our BIPOC patients state the same concerns time and time again?”
Our Newest Posts

New COVID-19 Research and HIV Intervention Breakthroughs Are on the Menu at CROI 2021
Arriving on the one-year anniversary of nationwide COVID-19 shutdowns, the 2021 Conference on Retroviruses and Opportunistic Infections won't be in person this year—but it will emphasize COVID-19 alongside important HIV prevention and treatment updates.

This Week in HIV Research: The Unsung Opportunities of Long-Acting Antiretrovirals
March 4, 2021: Improving care for PLWH in transition from incarceration; long-acting PrEP's potential in Black and Latinx communities; comorbidity rates and COVID-19 risk among PLWH; how COVID lockdowns affect the HIV epidemic.

Among Women in the U.S., Race and Place Play an Outsized Role in New HIV Infections
Beyond the big-picture improvements, a closer look at the data reveals stark racial and geographic disparities in HIV incidence and prevalence.

Where Does the Science Stand on COVID-19 Outcomes Among People Living With HIV?
The worst fears about HIV and COVID-19 don’t appear to have materialized, but concerns persist, particularly in cases where HIV treatment efficacy is suboptimal or comorbidities are present.

Older Adults Living With HIV Often Have Delayed Entry Into Care
A new study shows that almost two-thirds of older adults who were diagnosed with HIV at a Connecticut clinic were already at an advanced stage of disease progression.

Recent Research Highlights Difficulty in Measuring Heart Disease Risk for People Living With HIV
Two studies out of Europe aimed to give data on which patients with HIV benefit most from lipid-lowering medications, but they both ultimately concluded that better CVD risk-assessment tools—targeted specifically for PLWH—are needed.